GYNALGIN

This brand name is authorized in Lithuania, Poland

Active ingredients

The drug GYNALGIN contains a combination of these active pharmaceutical ingredients (APIs):

1 Chlorquinaldol
UNII D6VHC87LLS - CHLORQUINALDOL
Read about Chlorquinaldol
2 Methronidazole
UNII 140QMO216E - METRONIDAZOLE

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

Read about Methronidazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G01AF20 Combinations of imidazole derivatives G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AF Imidazole derivatives
Discover more medicines within G01AF20

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1010414
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100027757, 100336263, 100336530, 100336837, 100337759, 100353161, 100364472, 100414164

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.